Submitted by Anonymous (not verified) on 16 April 2024 - 15:30
Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 27, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 27, Status: Authorised